We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Kit Screens for Neurite Outgrowth Neurotoxin Inducers and Inhibitors

By HospiMedica staff writers
Posted on 20 Aug 2007
A new assay kit uses high-content screening for imaging and analysis of neurite outgrowth and neuronal cell morphology.

The kit utilizes high-quality, validated, target-specific detection reagents for profiling in a variety of species, including human, mouse, and rat. More...
Large-scale screening is simplified because the assay reagents are stable for 24-hours at room temperature.

The primary antibody is immunofluorescence-based to specifically label neurites and neuronal cell bodies in heterogeneous cell populations. High sensitivity-generating images with high signal-to-background ratios facilitate subsequent high content analysis, making the kit suitable for screening both inducers and inhibitors of neurite outgrowth neurotoxins.

Developed by Millipore corp. (Billerca, MA, USA), the new kit is called the Neurite Outgrowth assay. It is the newest assay kit in Millipore's drug discovery product line.

Millipore's Bioscience Division provides tools, services, and biologic reagents for LifeSciences and supports the discovery and development of new pharmaceuticals. Its product portfolio was enhanced in 2006 by the addition of the Chemicon, Upstate, and Linco product lines.


Related Links:
Millipore

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.